Answer
Letermovir is not recommended for patients with severe hepatic impairment (Child-Pugh Class C).
Sources for this answer
- PREVYMIS 240 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 14Document updated
Sources checked